Stock Chart

KRYS

$311.50 -2.70%
Score: 48.5 HOLD
LEAPs: SELL $400
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $400
Premium: $38.00
Expiry: Jun 17, 2027
Target: $373
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 0.98x (vs SPY: 1.2x | vs QQQ: 1.2x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 23, 2026
Falling Wedge Bullish scenario quality 71/100
Measured-move target $314.93 (+1.1%) · apex ~9 bars ahead
Historically breaks up 63% of the time; target hit in 75% of up-breaks (n=385)
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and target are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About KRYS - Krystal Biotech, Inc. Common Stock

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in …

Key Statistics

Market Cap $9B
P/E Ratio 40.12

This KRYS stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track KRYS's price movements with trendlines, gamma walls, and key support/resistance levels.